ciprofibrate has been researched along with Blood Pressure, High in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casanova, MA | 1 |
| Medeiros, F | 1 |
| Trindade, M | 1 |
| Cohen, C | 1 |
| Oigman, W | 1 |
| Neves, MF | 1 |
| Kandoussi, A | 1 |
| Martin, F | 1 |
| Hazzan, M | 1 |
| Noël, C | 1 |
| Fruchart, JC | 1 |
| Staels, B | 1 |
| Duriez, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Alpha Linolenic Acid (ALA) Supplementation on Essential Fatty Acids Profile During Pregnancy Compared to Common Supplements and the Epigenetic Effect on the Newborn[NCT03040856] | 0 participants (Actual) | Interventional | 2022-02-01 | Withdrawn (stopped due to Problems executing the study) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for ciprofibrate and Blood Pressure, High
| Article | Year |
|---|---|
Omega-3 fatty acids supplementation improves endothelial function and arterial stiffness in hypertensive patients with hypertriglyceridemia and high cardiovascular risk.
Topics: Adult; Cardiovascular Diseases; Endothelium, Vascular; Fatty Acids, Omega-3; Female; Fibric Acids; H | 2017 |
1 other study available for ciprofibrate and Blood Pressure, High
| Article | Year |
|---|---|
HMG-CoA reductase inhibition and PPAR- alpha activation both inhibit cyclosporin A induced endothelin-1 secretion in cultured endothelial cells.
Topics: Animals; Aorta; Cattle; Cells, Cultured; Clofibric Acid; Cyclosporine; Endothelin-1; Endothelium, Va | 2002 |